| Human aminoimidazole ribonucleotide synthetase | | homo-2-mer | 475-792 | 99.68 | 2×SO4; |
|
| Human GAR transformylase in complex with GAR substrate and AGF102 inhibitor | | homo-2-mer | 808-1007 | 100 | 2×GAR; 2×V97; |
|
| Human glycinamide ribonucleotide synthetase | | monomer | 1-429 | 99.76 | 1×CL; 1×SO4; 1×ATP; 2×GOL; |
|
| The structure of human glycinamide ribonucleotide transformylase in complex with 10S-methylthio-DDA… | | monomer | 808-1010 | 100 | 1×PO4; 2×SO4; 1×DXY; |
|
| The structure of human glycinamide ribonucleotide transformylase in complex with 10R-methylthio-DDA… | | monomer | 808-1010 | 100 | 1×PO4; 2×SO4; 1×DXZ; |
|
| human glycinamide ribonucleotide Transformylase at pH 4.2 | | monomer | 808-1010 | 100.0 | 1×PO4; 1×SO4; |
|
| High resolution structure of human glycinamide ribonucleotide transformylase in apo form. | | monomer | 810-1010 | 100 | 1×PO4; 3×SO4; |
|
| Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d… | | monomer | 808-1008 | 100 | 1×GAR; 1×G71; |
|
| HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({4-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YF; |
|
| HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (S)-2-({5-[3-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YG; |
|
| Human GAR transformylase in complex with GAR and (S)-2-(7-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YD; |
|
| Human GAR transformylase in complex with GAR and (S)-2-({4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YB; |
|
| Human GAR transformylase in complex with GAR and (S)-2-(8-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YE; |
|
| Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-… | | monomer | 808-1007 | 100 | 1×GAR; 1×3Y9; |
|
| Human GAR transformylase in complex with GAR and (S)-2-({5-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YC; |
|
| Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-3,4-dihydrothieno[2,3-d]pyr… | | monomer | 808-1007 | 100 | 1×GAR; 1×3YA; |
|
| human GAR Tfase in complex with hydrolyzed form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-… | | monomer | 808-1007 | 100 | 2×PO4; 1×KEU; |
|
| Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,… | | monomer | 808-1007 | 100 | 1×KT5; |
|
| Human GAR transformylase in complex with GAR and N-({5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d… | | monomer | 808-1007 | 100 | 1×GAR; 1×G94; |
|
| Human GAR transformylase in complex with GAR substrate and AGF132 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×XSI; |
|
| The structure of human glycinamide ribonucleotide transformylase in complex with alpha,beta-N-(hydr… | | monomer | 808-1007 | 100 | 1×GRF; 1×DQB; |
|
| AGF271 and GAR in complex with human recombinant GARFTase, ligase, purine biosynthesis, transfers f… | | monomer | 808-1007 | 100 | 1×GAR; 1×XRR; |
|
| Human GAR transformylase in complex with GAR substrate and AGF347 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×Y79; |
|
| Human GAR transformylase in complex with GAR substrate and AGF103 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×V9A; 1×NA; |
|
| Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,… | | monomer | 808-1007 | 100 | 1×KT5; |
|
| Human GAR transformylase in complex with GAR and (4-{[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d… | | monomer | 808-1007 | 99.5 | 1×GAR; 1×83A; |
|
| Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof… | | monomer | 808-1007 | 100 | 1×KEU; 1×GAR; |
|
| Human GAR Tfase complex structure with 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrof… | | monomer | 808-1007 | 100 | 2×PO4; 1×KEU; |
|
| Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor | | monomer | 808-1007 | 100 | 1×Y7L; 1×GAR; |
|
| The apo structure of human glycinamide ribonucleotide transformylase | | monomer | 808-1007 | 100 | 1×GOL; |
|
| Human GAR transformylase in complex with GAR substrate and AGF305 inhibitor | | monomer | 808-1007 | 99.5 | 1×GAR; 1×XSO; |
|
| Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,… | | monomer | 808-1007 | 100 | 1×PO4; 1×KT3; |
|
| Human GAR Tfase complex structure with polyglutamated 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,… | | monomer | 808-1007 | 100 | 2×PO4; 1×KT5; |
|
| Human GAR transformylase in complex with GAR substrate and AGF131 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×V9V; 1×NA; |
|
| Human GAR transformylase in complex with GAR substrate and AGF302 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×XSO; |
|
| Human GAR transformylase in complex with GAR and pemetrexed | | monomer | 808-1007 | 100 | 1×4DW; 1×GAR; |
|
| Human GAR transformylase in complex with GAR substrate and AGF362 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×Y72; |
|
| Human GAR transformylase in complex with GAR substrate and AGF291 inhibitor | | monomer | 808-1007 | 100 | 1×GAR; 1×Y6U; |
|
| Human Glycinamide Ribonucleotide Transformylase domain at pH 8.5 | | monomer | 810-1007 | 100 | 1×PO4; |
|
| complex structure of human GAR Tfase and substrate beta-GAR | | monomer | 810-1007 | 100 | 1×GAR; |
|